Beyond FSP1 there are therapeutic opportunities across the CoQ 10 oxidoreductase network While FSP1 currently has the strongest targetability signal, other CoQ 10 oxidoreductases may be therapeutically leveraged in defined genetic, metabolic or tissue contexts: (1) DHODH axis (mitochondrial defense in select contexts): DHODH connects pyrimidine synthesis to mitochondrial CoQ reduction, and in some settings, DHODH inhibition has been proposed to heighten ferroptosis sensitivity, especially in GPX4-low states
Stopping at six months leaves significant weight loss potential unrealized and insufficient time for metabolic and behavioral adaptation
Histologically, MNTI was consisted of large polygonal melanin-producing epithelioid cells and small round neuroblast-like cells which arranged in irregular alveolar, tubuloglandular and fissured architecture
The KLOW vs KPV which better comparison at the mechanistic level comes down to target tissue
Association Between Folate and Health Outcomes: An Umbrella Review of Meta-Analyses
Glutathione, Glutaredoxins, and Iron
.jpg)
